CD274 and neoplasm: The tumor-bearing mice were treated with anti-PD-1 antibody alone, anti-PD-L1 antibody alone, TTFields alone, TTFields with anti-PD-1 antibody, and TTFields with anti-PD-L1 antibody to evaluate and compare the anti-tumor efficacy of each treatment (Fig. 1a).